Pharmacological and functional properties of voltage-independent Ca2+ channels

Cell Calcium

Volumn 19, Issue 4, 1996, Pages 269-279

  Clementi, Emilio ^a,b,c   Meldolesi, Jacopo ^b  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION;

CALCIUM CELL LEVEL; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0029943444     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4160(96)90068-8     Document Type: Review

References (152)

1. 2+ influx at the plasma membrane: voltage-, receptor-, and second messenger-operated channels. Exp Cell Res 1987; 171: 271-283.
2. Kuno M., Gardner P. Ion channels activated by inositol 1,4,5-trisphosphate in plasma membrane of human T-lymphocytes. Nature 1987; 326: 301-304.
3. 2+ entry: toward a proliferation or a simplification?. FASEB J 1992; 6: 3085-3091.
4. 2+. Proc Natl Acad Sci USA 1992; 89: 509-513.
5. Putney Jr J.W. A model for receptor-regulated calcium entry. Cell Calcium 1986; 7: 1-12.
6. Putney Jr J.W. Capacitative calcium entry revisited. Cell Calcium 1990; 11: 611-624.
7. 2+ without generation of inositol phosphates in NG115-401L neuronal cells. Biochem J 1988; 253: 81-86.
8. 2+-ATPase. Proc Natl Acad Sci USA 1990; 87: 2466-2470.
9. 2+ influx. Two independently regulated mechanisms of influx stimulation coexist in neurosecretory PC12 cells. J Biol Chem 1992; 267: 2164-2172.
10. Thastrup O., Dawson A.P., Scharff O. et al. Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. Agents Actions 1989; 27: 17-23.
11. 2+ stores. Proc Natl Acad Sci USA 1993; 90: 6295-6299.
12. Hoth M., Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 1992; 355: 353-356.
13. 2+ influx: how many mechanisms for how many channels? Trends Pharmacol Sci 1994; 15: 71-86.
14. Clapham D.E. Intracellular calcium. Replenishing the stores. Nature 1995; 375: 634-635.
15. Felder C.C., Singer-Lahat D., Mathes C. Voltage-independent calcium channels. Regulation by receptors and intracellular calcium stores. Biochem Pharmacol 1994; 48: 1997-2004.
16. Berridge M.J. Capacitative calcium entry. Biochem J 1995; 312: 1-11.
17. 2+ mobilization in bovine adrenal chromaffin cells. Biochem J 1994; 304: 469-476.
18. 2+ entry pathway in differentiated HL60 cells. J Biol Chem 1994; 269: 29451-29456.
19. 2+ influx in T lymphocytes from patients with multiple sclerosis. Proc Natl Acad Sci USA 1994; 91: 4825-4829.
20. von Tscharner V., Prod'hom B., Baggiolini M., Reuter H. Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration. Nature 1986; 324: 369-372.
21. Gukovskaja A., Pandol S.J. Nitric oxide production regulates cGMP formation and calcium influx in pancreatic acinar cells. Am J Physiol 1994; 266: G350-G356.
22. Pandol S.J., Schoeffield-Payne M.S. Cyclic GMP regulates free cytosolic calcium in the pancreatic acinar cell. Cell Calcium 1990; 11: 477-486.
23. 2+ entry by noradrenaline involves cGMP in vascular myocytes. Cell Calcium 1995; 18: 505-514.
24. 2+-permeable channel. Nature 1992; 355: 356-358.
25. Hughes A.D., Schachter M. Multiple pathways for entry of calcium and other divalent cations in a vascular smooth muscle cell line (A7r5). Cell Calcium 1994; 15: 317-330.
26. 2+ influx in human neutrophils. Biochem J 1994; 297: 595-601.
27. 2+ responses are differentially modulated by nitric oxide via a cGMP-dependent pathway. Mol Pharmacol 1995; 48: 1068-1077.
28. 2+ influx. Eur J Pharmacol 1995; 289: 23-31.
29. Pfeifer A., Nurnberg B., Kamm S. et al. Cyclic GMP-dependent protein kinase blocks pertussis toxin-sensitive hormone receptor signaling pathways in Chinese hamster ovary cells. J Biol Chem 1995; 270: 9052-9059.
30. 2+ entry into colonic epithelial cells by NO and cGMP. Cell Calcium 1995; 17: 250-262.
31. + current by means of a phosphatase and a diffusible messenger. Nature 1993; 364: 814-818.
32. 2+ influx. Nature 1993; 364: 809-814.
33. Kim H.Y., Thomas D., Hanley M.R. Chromatographic resolution of an intracellular calcium influx factor from thapsigargin-activated Jurkat cells. Evidence for multiple activities influencing calcium elevation in Xenopus oocytes. J Biol Chem 1995; 270: 9706-9708.
34. Fasolato C., Hoth M., Penner R. A GTP-dependent step in the activation mechanism of capacitative calcium influx. J Biol Chem 1993; 268: 20737-20740.
35. Bird G.S., Putney Jr J.W. Inhibition of thapsigargin-induced calcium entry by microinjected guanine nucleotide analogues. Evidence for the involvement of a small G-protein in capacitative calcium entry. J Biol Chem 1993; 268: 21486-21488.
36. 2+ influx in HL-60 granulocytes involves GTP-sensitive elements. J Biol Chem 1993; 268: 26075-26078.
37. 2+ entry by tyrosine kinase inhibitors. J Biol Chem 1993; 268: 9945-9948.
38. 2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets. J Biol Chem 1993; 268: 18151-18156.
39. 2+ entry pathway of human neutrophils. J Biol Chem 1994; 269: 3963-3967.
40. Berlin R.D., Preston S.F. Okadaic acid uncouples calcium entry from depletion of intracellular stores. Cell Calcium 1993; 14: 379-386.
41. 2+ entry pathway in human neutrophils. J Biol Chem 1993; 268: 13055-13061.
42. 2+ entry in pancreatic acinar cells. J Biol Chem 1993; 268: 10808-10812.
43. 2+ influx. J Biol Chem 1994; 269: 12645-12653.
44. 2+ entry in rat pancreatic acinar cells. Biochem J 1995; 311: 649-656.
45. Geiger J., Nolte C., Walter U. Regulation of calcium mobilization and entry in human platelets by endothelium-derived factors. Am J Physiol 1994; 267: C236-C244.
46. 2+ release and influx responses in PC12-64 cells. Eur J Pharmacol 1995; 289: 113-123.
47. Geiger J., Nolte C., Butt E., Sage S.O., Walter U. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc Natl Acad Sci USA 1992; 89: 1031-1035.
48. 2+ and trp. Cell Calcium 1995; 18: 256-274.
49. Vaca L., Sinkins W.G., Hu Y., Kunze D.L., Schilling W.P. Activation of recombinant trp by thapsigargin in Sf9 insect cells. Am J Physiol 1994; 267: C1501-C1505.
50. Sinkins W.G., Vaca L., Kunze L.D., Schilling W.P. Thapsigargin regulation of Drosophila trp channel requires the COOH-terminal domain. Biophys J 1995; 68: A263.
51. Wes P.D., Chevesich J., Jeromin A., Rosenberg C., Stetten G., Monteil C. TRPC1, a human homolog of a Drosophila store-operated channel. Proc Natl Acad Sci USA 1995; 92: 9652-9656.
52. Petersen C.C.H., Berridge M.J., Borgese M.F., Bennett D.L. Putative capacitative calcium entry channels: expression of Drosophila trp and evidence for the existence of vertebrate homologues. Biochem J 1995; 311: 41-44.
53. Merritt J.E., Armstrong W.P., Benham C.D. et al. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 1990; 271: 515-522.
54. Krautwurst D., Hescheler J., Arndts D., Losel W., Hammer R., Schultz G. Novel potent inhibitor of receptor-activated nonselective cation currents in HL-60 cells. Mol Pharmacol 1993; 43: 655-659.
55. 2+ stores in HL-60 cells: evidence that a cytochrome P-450 is not involved. Biochem J 1994; 302: 187-190.
56. Franzius D., Hoth M., Penner R. Non-specific effects of calcium entry antagonists in mast cells. Pflügers Arch 1994; 428: 433-438.
57. 2+ Influx, Asilomar, CA, USA: 1995.
58. Leung Y.M., Kwan C.Y., Loh T.T. Dual effects of tetrandrine on cytosolic calcium in human leukaemic HL-60 cells: intracellular calcium release and calcium entry blockade. Br J Pharmacol 1994; 113: 767-774.
59. King V.F., Garcia M.L., Himmel D. et al. Interaction of tetrandrine with slowly inactivating calcium channels. J Biol Chem 1988; 263: 2238-2244.
60. 2+ antagonist: effects and mechanisms of action in vascular smooth muscle cells. J Pharmacol Exp Ther 1995; 273: 32-39.
61. Fasolato C., Pizzo P., Pozzan T. Receptor-mediated calcium influx in PC12 cells. ATP and bradykinin activate two independent pathways. J Biol Chem 1990; 265: 20351-20355.
62. 2+ transport pathways in thymic lymphocytes by econazole, miconazole, and SKF 96365. Am J Physiol 1993; 264:, C654-C662.
63. + channels. Life Sci 1994; 56: 295-306.
64. Schwarz G., Droogmans G., Nilius B. Multiple effects of SK&F 96365 on ionic currents and intracellular calcium in human endothelial cells. Cell Calcium 1994; 15: 45-54.
65. Krautwurst D., Degtiar V.E., Schultz G., Hescheler J. The isoquinoline derivative LOE908 selectively blocks vasopressin-activated nonselective cation currents in A7r5 aortic smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol 1994; 349: 310-317.
66. Loose D.S., Kan P.B., Hirst M.A., Marcus R.A., Feldman D. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J Clin Invest 1983; 71: 1495-1499.
67. Rodrigues A.D., Gibson G.G., Ioannides C., Parke D.V. Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins. Biochem Pharmacol 1987; 36: 4277-4281.
68. 2+ influx. Biochem J 1991; 274: 193-197.
69. 2+ stores. Kinetic evidence for a short-lived mediator. Biochem J 1992; 288: 519-525.
70. 2+ entry in human and bovine endothelial cells. J Physiol (Lond) 1995; 482: 259-274.
71. Vostal J.G., Fratantoni J.C. Econazole inhibits thapsigargin-induced platelet calcium influx by mechanisms other than cytochrome P-450 inhibition. Biochem J 1993; 295: 525-529.
72. 2+ signalling pathways. Cell Calcium 1994; 16: 413-418.
73. Wolff D.J., Datto G.A., Samatovicz R.A. The dual mode of inhibition of calmodulin-dependent nitric oxide synthase by antifungal imidazole agents. J Biol Chem 1993; 268: 9430-9436.
74. Bogle R.G., Whitley G.St.J., Soo S-C., Johnstone A.P., Vallance P. Effect of anti-fungal imidazole on mRNA levels and enzyme activity of inducible nitric oxide synthase. Br J Pharmacol 1994; 111: 1257-1261.
75. 3 and chromaffin cells by imidazole antimycotics and other cytochrome P-450 blockers. FASEB J 1992; 6: 2742-2747
76. + channels by cytochrome P-450 inhibitors. J Biol Chem 1992; 267: 11789-11793.
77. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 1993; 92: 520-526.
78. + currents in pulmonary arterial myocytes. Am J Physiol 1995; 286: C259-C270.
79. Ishikawa S., Manabe S., Wada O. Miconazole inhibition of platelet aggregation by inhibiting cyclooxygenase. Biochem Pharmacol 1986; 35: 1787-1792.
80. Tornquist K., Ekokoski E., Forss L. TRH-evoked entry of extracellular calcium in GH4C1 cells: possible importance of arachidonic acid metabolites. Mol Cell Endocrinol 1994; 102: 103-110.
81. Ritter J.K., Franklin M.R. Clotrimazole induction of cytochrome P-450: dose-differentiated isozyme induction. Mol Pharmacol 1987; 31: 135-139.
82. Hosteller K.A., Wrighton S.A., Molowa D.T., Thomas P.E., Levin W., Guzelian P.S. Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents. Mol Pharmacol 1989; 35: 279-285.
83. - channels in Xenopusoocytes. Mol Pharmacol 1990; 37: 720-724.
84. 2+-activated chloride and potassium currents in smooth muscle cells. Br J Pharmacol 1994; 112: 977-984.
85. Marten I., Zeilinger C., Redhead C., Landry D.W., al-Awquati Q., Heidrich R. Identification and modulation of a voltage-dependent anion channel in the plasma membrane of guard cells by high-affinity ligands. EMBO J 1992; 11: 3569-3575.
86. Hughes B.A., Segawa Y. cAMP-activated chloride current in amphibian retinal pigment epithelial cells. J Physiol (Lond) 1993; 466: 749-766.
87. Ca channels by niflumic, flufenamic and mefenamic acids. Biophys J 1994; 67: 2272-2279.
88. K channels expressed in Xenopus oocytes. Mol Pharmacol 1994; 46: 750-753.
89. Zwart R., Oortgiesen M., Vijverberg H.P. Differential modulation of α3β2 and α3β4 neuronal nicotinic receptors expressed in Xenopus oocytes by flufenamic acid and niflumic acid. J Neurosti 1995; 15: 2168-2178.
90. Capdevila J., Gil L., Orellana M., Marnett L.J., Yadagiri P., Falck J.R. Inhibitors of cytochrome P450-dependent arachidonic acid metabolism. Arch Biochem Biophys 1988; 261: 257-263.
91. + channel by polyunsaturated fatty acids. Proc Natl Acad Sci USA 1994; 91: 1937-1944.
92. Tornquist K., Ekokoski E., Forss L., Matsson M. Importance of arachidonic acid metabolites in regulating ATP-induced calcium fluxes in thyroid FRTL-5 cells. Cell Calcium 1994; 15: 153-161.
93. Ekokoski E., Tornquist K. Effects of 5,8,11,14-eicosatetraynoic acid on thapsigargin-induced calcium entry, and intracellular pH in thyroid FRTL-5 cells. Biochim Biophys Acta 1994; 1223: 274-278.
94. Huang J.M., Xian H., Bacaner M. Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci USA 1992; 89: 6452-6456.
95. 3 cells. Am J Physiol 1992; 263: E903-E912.
96. McDougall P., Markham A., Cameron I., Sweetman A.J. Action of a nonsteroidal anti-inflammatory agent, flufenamic acid, on calcium movements in isolated mitochondria. Biochem Pharmacol 1988; 37: 1327-1330.
97. Lukacs G.L., Nanda A., Rotstein O.D., Grinstein S. The chloride channel blocker NPPB uncouples mitochondria and increases the proton permeability of the plasma membrane in phagocytic cells. FEBS Lett 1991; 288: 17-20.
98. Heiser R.W., Cheng C.C., Pardini R.S. Inhibition of mitochondrial electron transport by partially demethylated dihydroguaiaretic acid. Pharmacol Res Commun 1977; 9: 917-925.
99. Wilson D.E., Anderson K.M., Seed T.M. Ultrastructural evidence for differentiation in a human glioblastoma cell line treated with inhibitors of eicosanoid metabolism. Neurosurgery 1990; 27: 523-531.
100. Anderson K.M., Harris J.E. Targetted destruction of PC3 mitochondria by ETYA: a 'Trojan horse' membrane-suicide molecule. Med Hypotheses 1991; 35: 151-153.
101. 2+ influx dependent on store depletion by intracellular adenine-guanine nucleotide levels. J Biol Chem 1994; 269: 23597-23602.
102. O'Rourke B., Backx P.H., Marban E. Phosphorylation-independent modulation of L-type calcium channels by magnesium-nucleotide complexes. Science 1992; 257: 245-248.
103. Anderson M.P., Berger H.A., Rich D.P., Gregory R.J., Smith A.E., Welsh M.J. Nucleoside triphosphates are required to open the CFTR chloride channel. Cell 1991; 67: 775-778.
104. + channels in pancreatic B-cells. Nature 1984; 311: 271-273.
105. McNiff P., Svensson L., Pazoles C.J., Gabel C.A. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. J Immunol 1994; 153: 2180-2193.
106. Clark D.L., Linden J. Modulation of uanylate cyclase by lipooxygenase inhibitors. Hypertension 1986; 8: 947-950.
107. Snider R.M., Richelson E. Bradykinin receptor-mediated cyclic GMP formation in a nerve cell population. J Neurochem 1984; 43: 1749-1754.
108. Fischer G.A., Clementi E., Raichman M., Sudhof T., Ullrich A., Meldolesi J. Stable expression of truncated inositol 1,4,5-trisphosphate receptor subunits in 3T3 fibroblasts. J Biol Chem 1994; 269: 19216-19224.
109. Rasmussen C.D., Means A.R. Calmodulin, cell growth and gene expression. Trends Neurosci 1989; 12: 433-438.
110. Ghosh T.K., Bian J., Short A.D., Rybak S.L., Gill D.L. Persistent intracellular calcium pool depletion by thapsigargin and its influence on cell growth. J Biol Chem 1991; 266: 24690-24697.
111. Benzaquen L.R., Brugnara C., Byers H.R., Gattoni-Celli S., Halperin J.A. Clotrimazole inhibits cell proliferation in vitro and in vivo. Nature Med 1995; 6: 534-540.
112. Reist R.H., Dey R.D., Durham J.P., Rojanasakul Y., Castranova V. Inhibition of proliferative activity of pulmonary fibroblasts by tetrandrine. Toxicol Appl Pharmacol 1993; 122: 70-76.
113. Hupe D.J., Pfefferkorn E.R., Behrens N.D., Peters K. L-651,582 inhibition of intracellular parasitic protozoal growth correlates with host-cell directed effects. J Pharmacol Exp Ther 1991; 256: 462-467.
114. Hupe D.J., Boltz R., Cohen C.J. et al. The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651,582. J Biol Chem 1991; 266: 10136-10142.
115. Nordstrom T., Nevanlinna H.A., Andersson L.C. Mitosisarresting effect of the calcium channel inhibitor SK&F 96365 on human leukemia cells. Exp Cell Res 1992; 202: 487-494.
116. 2+ channel blocker. Cancer Lett 1993; 72: 77-81.
117. 2+ current, Il-2 production and activation in T lymphocytes. Br J Pharmacol 1994; 113: 861-868.
118. Barbiero G., Munaron L., Antoniotti S., Baccino F.M., Bonelli G., Lovisolo G. Role of mitogen-induced calcium influx in the control of the cell cycle in Balb-c 3T3 fibroblasts. Cell Calcium 1995; 18: 542-556.
119. Magni M., Meldolesi J., Pandiella A. Ionic events induced by epidermal growth factor. J Biol Chem 1991; 266: 6329-6335.
120. Kohn E.C., Liotta L.A. L 651,582: a novel antiproliferative and antimetastasis agent. J Natl Cancer Inst 1990; 82: 54-60.
121. Teicher B.A., Holden S.A., Chen Y.N., Ara G., Korbut T.T., Northey D. CAI: effects on cytotoxic therapies in vitro and in vivo. Cancer Chemother Pharmacol 1994; 34: 515-521.
122. Cole K., Kohn E. Calcium-mediated signal transduction: biology, biochemistry, and therapy. Cancer Metastasis Rev 1994; 13: 31-44.
123. Kohn E. Aging issues in invasion and metastasis. Fertile ground for investigation. Cancer 1993; 71: 552-557.
124. Partiseti M., Le Deist F., Hivroz C., Fischer A., Korn H., Choquet D. The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J Biol Chem 1994; 269: 32327-32335.
125. McNiff P.A., Laliberte R.E., Svensson L., Pazoles C.J., Gabel C.A. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent. Cytokine 1995; 7: 196-208.
126. 4 secretion in human peripheral blood mononuclear cells. Biochem Cell Biol 1994; 72: 397-402.
127. Golding S., Emery P., Young S.P. Tenidap-modulated proinflammatory cytokine activation of a monocyte cell line. J Immunol 1995; 154: 5384-5390.
128. Laliberte R., Perregaux D., Svensson L., Pazoles C.J., Gabel C.A. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. J Immunol 1994; 153: 2168-2179.
129. Pelletier J.P., McCollum R., DiBattista J., Loose L.D., Cloutier J.M., Martel-Pelletier J. Regulation of human normal and osteoarthritic chondrocyte interleukin-1 receptor by antirheumatic drugs. Arthritis Rheum 1993; 36: 1517-1527.
130. Raiss R.X., Karbowshi A., Aigner T., Schlryerbach R. Chondrocytes and antirheumatic drugs. J Rheumatol 1995; 43 Suppl: 152-154.
131. Mattey D.L., Evans E., Dawes P.T. The effects of tenidap on cytokine induced proliferation of human synovial fibroblasts in vitro. Ann Rheum Dis 1994; 53: 250-255.
132. Blackburn W.D., Loose L.D., Heck L.W., Chatham W.W. Tenidap, in contrast to several available nonsteroidal antiinflammatory drugs, potently inhibits the release of activated neutrophil collagenase. Arthritis Rheum 1991; 34: 211-216.
133. Dingle J.T., Leeming M.R., Martindale J.J. Effect of tenidap on cartilage integrity in vitro. Ann Rheum Dis 1993; 52: 292-299.
134. Madhok R. Tenidap. Lancet 1995; 346: 481-485.
135. Breedveld F. Tenidap: a novel cytokine-modulating antirheumatic drug for the treatment of rheumatoid arthritis. Scand J Rheumatol 1994; 100: 31-44.
136. Bia M.J., Insogna K. Treatment of sarcoidosis-associated hypercalcemia with ketoconazole. Am J Kidney Dis 1991; 18: 702-705.
137. Glass A.R., Cerletty J.M., Elliott W., Lemann Jr J., Gray R.W., Eil C. Ketoconazole reduces elevated serum levels of 1,25-dihydroxyvitamin D in hypercalcemic sarcoidosis. J Endocrinol Invest 1990; 13: 407-413.
138. Saggese G., Bertelloni S., Baroncelli G.I., Di Nero G. Ketoconazole decreases the serum ionized calcium and 1,25-dihydroxyvitamin D levels in tuberculosis-associated hypercalcemia. Am J Dis Child 1993; 147: 270-273.
139. Fanger C.M., Hoth M., Crabtree G.R., Lewis R.S. Characterization of T cell mutants with defective capacitative calcium entry. J Cell Biol 1995; 131: 655-667.
140. 2+ extrusion. Eur J Pharmacol 1990; 188: 417-421.
141. 2+ store depletion in human platelets is more susceptible to cytochrome P-450 inhibitors than receptor-mediated calcium entry. Cell Calcium 1992; 13: 553-564.
142. 2+ stores. Biochem J 1993; 289: 761-766.
143. 2+ stores of human neutrophils. Biochim Biophys Acta 1993; 1177: 127-133.
144. Goligorsky M.S., Menton D.N., Laszlo A., Lum H. Nature of thrombin-induced sustained increase in cytosolic calcium concentration in cultured endothelial cells. J Biol Chem 1989; 264: 16771-16775.
145. Cleveland P.L., Millard P.J., Showell H.J., Fewtrell C.M. Tenidap: a novel inhibitor of calcium influx in a mast cell line. Cell Calcium 1993; 14: 1-16.
146. - channel blockers inhibits secretion from rat mucosal-type mast cells. Mol Pharmacol 1995; 47: 1014-1020.
147. + channel blockers in colonic epithelial cells. Pflügers Arch 1992; 422: 48-54.
148. 2+ concentration by thapsigargin and cyclopiazonic acid in human aortic endothelial cells. Eur J Pharmacol 1995; 28: 131-137.
149. 2+ release by flufenamic acid and other blockers of the non-selective cation channel. FEBS Lett 1992; 296: 245-248.
150. 2+ influx in the epithelial cell line CFPAC-1. Pflügers Arch 1994; 428: 583-589.
151. Chen S., Inoue R., Ito Y. Pharmacological characterization of muscarinic receptor-activated cation channels in guinea-pig ileum. Br J Pharmacol 1993; 109: 793-801.
152. Kankaanranta H., Moilanen E. Flufenamic and tolfenamic acid inhibit calcium influx in human polymorphonuclear leukocytes. Mol Pharmacol 1995; 47: 1006-1013.